mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
4e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |